In re GeneIQ, LLC – Trademark Ex Parte Appeal TTAB Proceeding 88863737

This Ex Parte Appeal was filed at the USPTO Trademark Trial and Appeal Board (TTAB) on October 06, 2021 and assigned serial number 88863737 by the TTAB.

Plaintiff:
GeneIQ, LLC represented by DANICA L MATHES of BELL NUNNALLY & MARTIN LLP.
Trademark Information: GENEIQ THE RIGHT MEDICATION THE FIRST TIME – US Trademark Serial Number 88863737
View Trademark Status at USPTO
View Trademark Documents at USPTO

********

Prosecution History:
October 06, 2021 – APPEAL TO BOARD
October 27, 2021 – APPEAL ACKNOWLEDGED; CASE REMANDED
October 27, 2021 – INSTITUTED
January 10, 2022 – RECON DENIED
January 11, 2022 – PROCEEDINGS RESUMED
March 11, 2022 – FIRST REQ TO EXT TIME TO FILE MAIN BRIEF
March 15, 2022 – FIRST REQ TO EXT TIME TO FILE MAIN BRIEF GRANTED
April 11, 2022 – APPEAL BRIEF
April 11, 2022 – APPEAL FORWARDED TO EXAMINER FOR BRIEF
June 08, 2022 – EXAMINER’S MOT TO CONSOLIDATE
June 13, 2022 – APPEAL FORWARDED TO EXAMINER FOR BRIEF
June 23, 2022 – EXAMINER’S BRIEF
June 23, 2022 – EXAMINER’S BRIEF
July 13, 2022 – REPLY BRIEF
July 15, 2022 – REPLY BRIEF
July 28, 2022 – MEMO FORWARDING REPLY BRIEF
July 28, 2022 – SUBMITTED FOR FINAL DECISION
September 29, 2022 – FINAL DECISION: AFFIRMED
View this TTAB Proceeding at USPTO

About Select IP
Select IP Law Corporation monitors TTAB proceedings that have been instituted. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.